Indications and uses
helps eliminate the symptoms of dandruff
Drug Facts
- Manufacturer
- PRODUCTOS CAPILARES LOREAL SA
- Effective date
- 2024-06-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:00:19
Label at a glance#
ProductKerastase Paris K Symbiose Scalp Renewal Micro Exfoliating Scrub Antidandruff Treatment
Active ingredientSALICYLIC ACID
Label structure10 sections
Dosage and administration
for best results use at least twice a week or as directed by a doctor apply to hair massage rinse
Label contents#
Full prescribing information#
Active ingredient
Salicylic acid 1.9%
Purpose
Antidandruff
Uses
- helps eliminate the symptoms of dandruff
Warnings
For external use only
When using this product
avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor if
condition worsens or does not improve after regular use of this product as directed
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- for best results use at least twice a week or as directed by a doctor
- apply to hair
- massage
- rinse
Inactive ingredients
water, sodium laureth sulfate, sodium lauryl sulfate, glycerin, cocamide MEA, coco-betaine, laureth-5 carboxylic acid, acrylates copolymer, cocamide MIPA, sodium hydroxide, citric acid, sodium benzoate, argania spinosa shell powder, prunus armeniaca (apricot) seed powder, hexylene glycol, sodium chloride, menthol, polyquaternium-10, isopropyl myristate, PEG-55 propylene glycol oleate, propylene glycol, limonene, squalene, capryloyl salicylic acid, benzyl salicylate, benzyl alcohol, linalool, citronellol, citral, geraniol, artemisia umbelliformis flower extract,
potassium sorbate, fragrance
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- Kerastase Paris K Symbiose Scalp Renewal Micro Exfoliating Scrub Antidandruff Treatment
- Salicylic Acid
- WATER
- SODIUM LAURETH SULFATE
- SODIUM LAURYL SULFATE
- GLYCERIN
- COCO MONOETHANOLAMIDE
- COCO-BETAINE
- LAURETH-5 CARBOXYLIC ACID
- BUTYL ACRYLATE/METHYL METHACRYLATE/METHACRYLIC ACID COPOLYMER (18000 MW)
- COCO MONOISOPROPANOLAMIDE
- SODIUM HYDROXIDE
- CITRIC ACID MONOHYDRATE
- SODIUM BENZOATE
- ARGAN SHELL
- PRUNUS ARMENIACA SEED
- HEXYLENE GLYCOL
- SODIUM CHLORIDE
- MENTHOL
- POLYQUATERNIUM-10 (10000 MPA.S AT 2%)
- ISOPROPYL MYRISTATE
- PEG-55 PROPYLENE GLYCOL OLEATE
- PROPYLENE GLYCOL
- LIMONENE, (+)-
- SQUALANE
- CAPRYLOYL SALICYLIC ACID
- BENZYL SALICYLATE
- BENZYL ALCOHOL
- LINALOOL, (+/-)-
- .BETA.-CITRONELLOL, (R)-
- CITRAL
- GERANIOL
- ARTEMISIA UMBELLIFORMIS FLOWER
- POTASSIUM SORBATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 83342-136 | 83342-136-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 664b1fcb-6fd2-40cc-ae65-8daf733f9d10 | 75f06d6b-af07-43e6-8d00-da7fbb2d7e23 | 2024-06-20 | Warnings | 664b1fcb-6fd2-40cc-ae65-8daf733f9d10 75f06d6b-af07-43e6-8d00-da7fbb2d7e23 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.